Cargando…

Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme

Australia has had a government subsidized universal system of pharmaceutical provision for 50 years. The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it w...

Descripción completa

Detalles Bibliográficos
Autor principal: Duckett, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194861/
https://www.ncbi.nlm.nih.gov/pubmed/15229996
_version_ 1782339202655977472
author Duckett, Stephen J.
author_facet Duckett, Stephen J.
author_sort Duckett, Stephen J.
collection PubMed
description Australia has had a government subsidized universal system of pharmaceutical provision for 50 years. The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. It incorporates patient copayments (with differentials for the general population compared with concessional beneficiaries). Prior to listing a drug on the PBS it is subject to a rigorous cost-effectiveness analysis.
format Online
Article
Text
id pubmed-4194861
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41948612014-11-04 Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme Duckett, Stephen J. Health Care Financ Rev Research Article Australia has had a government subsidized universal system of pharmaceutical provision for 50 years. The Pharmaceutical Benefits Scheme (PBS) consumes around 14 percent of total government health care expenditures and has grown substantially in both range of drugs covered, and expenditure since it was first introduced in 1950. It incorporates patient copayments (with differentials for the general population compared with concessional beneficiaries). Prior to listing a drug on the PBS it is subject to a rigorous cost-effectiveness analysis. CENTERS for MEDICARE & MEDICAID SERVICES 2004 /pmc/articles/PMC4194861/ /pubmed/15229996 Text en
spellingShingle Research Article
Duckett, Stephen J.
Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title_full Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title_fullStr Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title_full_unstemmed Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title_short Drug Policy Down Under: Australia's Pharmaceutical Benefits Scheme
title_sort drug policy down under: australia's pharmaceutical benefits scheme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194861/
https://www.ncbi.nlm.nih.gov/pubmed/15229996
work_keys_str_mv AT duckettstephenj drugpolicydownunderaustraliaspharmaceuticalbenefitsscheme